UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.17 Million Stock Holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its position in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS) by 7.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 108,615 shares of the company’s stock after selling 9,100 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Integral Ad Science were worth $1,174,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in IAS. SG Americas Securities LLC acquired a new position in Integral Ad Science during the second quarter worth about $392,000. Nisa Investment Advisors LLC lifted its stake in shares of Integral Ad Science by 449,805.3% in the 2nd quarter. Nisa Investment Advisors LLC now owns 427,410 shares of the company’s stock valued at $4,154,000 after acquiring an additional 427,315 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Integral Ad Science by 30.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 274,734 shares of the company’s stock valued at $2,670,000 after acquiring an additional 63,839 shares in the last quarter. Principal Financial Group Inc. grew its position in Integral Ad Science by 9.3% during the 2nd quarter. Principal Financial Group Inc. now owns 61,108 shares of the company’s stock worth $594,000 after acquiring an additional 5,189 shares during the last quarter. Finally, Versor Investments LP bought a new position in Integral Ad Science in the second quarter valued at about $262,000. 95.78% of the stock is currently owned by institutional investors.

Integral Ad Science Trading Up 0.1 %

IAS opened at $10.45 on Wednesday. The firm has a market capitalization of $1.70 billion, a PE ratio of 52.25, a P/E/G ratio of 1.49 and a beta of 1.45. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. Integral Ad Science Holding Corp. has a fifty-two week low of $7.98 and a fifty-two week high of $17.53. The company’s 50-day moving average is $11.15 and its 200 day moving average is $10.68.

Integral Ad Science (NASDAQ:IAS) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. The business had revenue of $133.50 million for the quarter, compared to analysts’ expectations of $138.06 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.09) earnings per share. As a group, research analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO Lisa Utzschneider sold 10,481 shares of the stock in a transaction on Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $105,962.91. Following the completion of the transaction, the chief executive officer now owns 239,709 shares in the company, valued at approximately $2,423,457.99. This represents a 4.19 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Tania Secor sold 5,240 shares of the business’s stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the sale, the chief financial officer now owns 248,223 shares in the company, valued at $2,509,534.53. This represents a 2.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 16,363 shares of company stock valued at $165,629. 2.00% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on IAS. Scotiabank assumed coverage on Integral Ad Science in a research note on Thursday, December 5th. They issued a “sector perform” rating and a $10.00 price objective for the company. Craig Hallum decreased their price objective on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Piper Sandler reduced their price target on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 13th. Oppenheimer lowered their price objective on Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, November 13th. Finally, Benchmark restated a “hold” rating on shares of Integral Ad Science in a research report on Thursday, November 14th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, Integral Ad Science has an average rating of “Moderate Buy” and an average price target of $15.18.

Integral Ad Science Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.